Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$70,833.00

Engineering a nanofactory for cytosolic manufacturing of shRNA in living cells

FY 2015-16

Summary
Ribonucleic acids (RNA) are a powerful class of therapeutics for a variety of diseases, but are difficult to deliver into the cytoplasm of cells where they exert their function. This project will engineer a molecular device which, instead of solely relying on delivery, can manufacture RNA directly within the cell cytoplasm. This strategy not only amplifies the therapeutic dose of RNA available at its site-of-action, but also reduces its non-specific interactions elsewhere in the host. Therefore, the device has the potential to improve the efficacy of RNA-based drugs while reducing their side-effects.
Program
CIHR Fellowship
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
338638
Name
Chou Leo
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Engineering a nanofactory for cytosolic manufacturing of shRNA in living cells
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$70,833
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bio-Inspired Engineering; Biomaterials; Cancer Therapy; Dna Nanotechnology; Nanomedicine; Rna Therapeutics; Sirna/Shrna
Abstract
Ribonucleic acids (RNA) are a powerful class of therapeutics for a variety of diseases, but are difficult to deliver into the cytoplasm of cells where they exert their function. This project will engineer a molecular device which, instead of solely relying on delivery, can manufacture RNA directly within the cell cytoplasm. This strategy not only amplifies the therapeutic dose of RNA available at its site-of-action, but also reduces its non-specific interactions elsewhere in the host. Therefore, the device has the potential to improve the efficacy of RNA-based drugs while reducing their side-effects.
Competitiondate
201511
Approvedterm2
1 yr 5 mths
Pinamesdelim
Chou, Leo
Approvedterm
1 an 5 mois
Cihrcontribution2
~ $70,833~ $0~
Direct Payment - $70,833 Grant (2015-16) | Canada Spends